BioSpace News Archive

Market Leader in Radar Sensors Recognized by DHS for Innovative Applications

Bio-Techne has announced a corporate initiative to advance cell and gene therapy research and ex vivo cell processing.

Shionogi & Co., Ltd. announced today that 14 presentations will feature the company’s investigational compounds at IDWeek™ 2018, in San Francisco, October 3-7, 2018.

TTP Labtech Ltd, an international leader in the design and development of automated instrumentation and consumables for life science research is pleased to announce that investment from Battery Ventures has underpinned their aggressive growth plans.

BioUtah today announced that the board of directors has selected Kelvyn H. Cullimore Jr. as its president and CEO. Cullimore will succeed Kelly Slone, who has served in that capacity for the past three years.

Phase II grant to support development of innovative exosome characterization platform

Award recognizes excellence in providing parent-friendly benefits and a supportive work environment for working parents

Lands’ End is raising awareness and funding for the Breast Cancer Research Foundation through the annual Pink Thread Project. From now through October 31, Lands’ End offers three ways to donate to life-saving research.

The Weekly Ask Dr. Pane Series has Been Immensely Popular, Reaching Over 112,000 Views

IO Biotech, a clinical-stage biopharmaceutical company developing novel, immune modulating anti-cancer therapies, based on its proprietary T-win® technology, announces that the first patient has received the first dose in an international Phase I/II clinical trial studying the investigational candidate IO102 in combination with KEYTRUDA® (pembrolizumab) for patients with non-small cell lung cancer (NSCLC) – NCT03562871.